Each component is compounded to assist in key metabolic functions
There are four approved sites for the subcutaneous injection of insulin: Abdomen : You can do an injection anywhere outside a two-centimetre (or two-finger) radius around the navel
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up
Adjusting Dosage : Transitioning from semaglutide to tirzepatide may involve titrating doses to ensure seamless continuity in weight loss program and prevent severe side effects
4c) with only a slight but significant decrease in lean tissue mass (Fig
Poor sleep quality disrupts hormones that regulate appetite and cravings